Important Update

Statement regarding Aethlon’s position with respect to the potential for use of the Hemopurifier as a countermeasure against the current coronavirus SARS-CoV-2 (COVID-19) outbreak

Recent News

November 3, 2020

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer

October 28, 2020

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

View All News

Recent Events

Oct 28, 2020 • 4:30pm EST

Second Quarter 2021 Investor Call

Sep 15, 2020 • 8:00am PST

Annual Meeting of Stockholders

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up